Marnix Van Loock

13PUBLICATIONS
68CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsEpidemiological methodsBiomolecular modelling and designMedical virologyMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 05, 2025
A New Fragment-Based Pharmacophore Virtual Screening Workflow Identifies Potent Inhibitors of SARS-CoV-2 NSP13 Helicase.

Jordi Doijen, Jiexiong Xie, Simone Marsili

|Jul 30, 2025
A Prospective Cohort Study of Primary Dengue Virus Infection in Medellín, Colombia.

Andrea Trujillo, Liesbeth Van Wesenbeeck, Lina Salazar

|Mar 27, 2025
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.

Ellen Van Damme, Pravien Abeywickrema, Yanting Yin

|Jul 19, 2024
Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation.

Dominik Kiemel, Ann-Sophie Helene Kroell, Solène Denolly

|May 10, 2023
Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers.

Oliver Ackaert, Frédéric Vanhoutte, Nathalie Verpoorten

|Mar 17, 2023
A phylogenetic study of dengue virus in urban Vietnam shows long-term persistence of endemic strains.

James Ashall, Sonal Shah, Joseph R Biggs

Pageof 3

Frequent Collaborators

5 joint publications

Johan Neyts

4 joint publications

Ralf Bartenschlager

4 joint publications

Suzanne J F Kaptein

3 joint publications

Franck Touret